blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2109445

EP2109445 - COMPOSITIONS FOR TOPICAL APPLICATION COMPRISING A PEROXIDE AND RETINOID [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  24.02.2023
Database last updated on 18.11.2024
FormerThe patent has been granted
Status updated on  18.03.2022
FormerGrant of patent is intended
Status updated on  22.11.2021
FormerExamination is in progress
Status updated on  16.10.2021
FormerGrant of patent is intended
Status updated on  13.07.2021
FormerExamination is in progress
Status updated on  22.11.2016
Most recent event   Tooltip15.11.2024Change - lapse in a contracting state
Updated state(s): BG		published on 18.12.2024 [2024/51]
Applicant(s)For all designated states
Sol-Gel Technologies Ltd.
Weizmann Science Park
7 Golda Meir St.
Ness Ziona 7403650 / IL
[2021/32]
Former [2017/38]For all designated states
Sol-Gel Technologies Ltd.
Golda Meir Street 7
Weizmann Science Park
74036 Ness Ziona / IL
Former [2009/43]For all designated states
Sol-Gel Technologies Ltd.
Industrial Zone West
Beit Shemesh 99100 / IL
Inventor(s)01 / TOLEDANO, Ofer
15A Emek Zvulon Street
4462317 Kfar Saba / IL
02 / SERTCHOOK, Hanan
3 Lilienblum St.
7042703 Gedera / IL
03 / LOBODA, Natalia
Ha Rav Tene Shlomo 22/31
Beer Sheva, 8449667 / IL
04 / BAR-SIMANTOV, Haim
12 Iyar Street
Netanya 4250341 / IL
05 / SHAPIRO, Leora
12 Oved Street
9355115 Jerusalem / IL
06 / ABU-REZIQ, Raed
P.O.Box 70
30091 Jatt Hamesholash / IL
 [2022/16]
Former [2021/12]01 / TOLEDANO, Ofer
15A Emek Zvuloon Street
44623 Kfar-saba / IL
02 / SERTCHOOK, Hanan
3 Lilienblum St.
70700 Gedera / IL
03 / LOBODA, Natalia
Ha Rav Tene Shlomo 22/31
Beer Sheva, 8449667 / IL
04 / BAR-SIMANTOV, Haim
11 Migdal Oz Street
71700 Modiin / IL
05 / SHAPIRO, Leora
12 Oved street
93551 Jerusalem / IL
06 / ABU-REZIQ, Raed
P.O.Box 70
30091 Jatt Hamesholash / IL
Former [2009/43]01 / TOLEDANO, Ofer
15A Emek Zvuloon Street
44623 Kfar-saba / IL
02 / SERTCHOOK, Hanan
23 Katznelson Street
70700 Gedera / IL
03 / LOBODA, Natalia
16/18 Shlomo Ben-Yossef Street
93811 Jerusalem / IL
04 / BAR-SIMANTOV, Haim
11 Migdal Oz Street
71700 Modiin / IL
05 / SHAPIRO, Leora
12 Oved street
93551 Jerusalem / IL
06 / ABU-REZIQ, Raed
P.O.Box 70
30091 Jatt Hamesholash / IL
Representative(s)Pearl Cohen Zedek Latzer Baratz UK LLP
The Gridiron Building
One Pancras Square
London N1C 4AG / GB
[2022/16]
Former [2009/43]Brown, David Leslie
Haseltine Lake LLP Redcliff Quay 120 Redcliff Street Bristol
BS1 6HU / GB
Application number, filing date08702719.903.02.2008
[2009/43]
WO2008IL00140
Priority number, dateUS20070898701P01.02.2007         Original published format: US 898701 P
[2009/43]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2008093346
Date:07.08.2008
Language:EN
[2008/32]
Type: A2 Application without search report 
No.:EP2109445
Date:21.10.2009
Language:EN
The application published by WIPO in one of the EPO official languages on 07.08.2008 takes the place of the publication of the European patent application.
[2009/43]
Type: B1 Patent specification 
No.:EP2109445
Date:20.04.2022
Language:EN
[2022/16]
Search report(s)International search report - published on:EP28.05.2009
ClassificationIPC:A61K9/00, A61K9/28, A61K47/34, A61P17/00, A61P17/06, A61P17/10, A61P17/16, A61P31/00, A61P29/00, A61K31/203, A61K31/327, A61K31/4436, A61K33/40
[2021/29]
CPC:
A61K9/0014 (EP,US); A61K9/16 (KR); A61K31/203 (EP,KR);
A61K31/327 (EP,KR); A61K31/4436 (EP); A61K47/34 (EP,US);
A61K9/28 (EP,US); A61P17/06 (EP); A61P17/10 (EP);
A61P17/16 (EP) (-)
C-Set:
A61K31/203, A61K2300/00 (EP);
A61K31/327, A61K2300/00 (EP)
Former IPC [2021/26]A61K9/00, A61K9/28, A61K47/34, A61P17/00, A61P17/06, A61P17/10, A61P17/16, A61P31/00, A61P29/00
Former IPC [2009/43]A61K9/16, A61K9/50, A61K9/00
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2022/16]
Former [2009/43]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MT,  NL,  NO,  PL,  PT,  RO,  SE,  SI,  SK,  TR 
TitleGerman:ZUSAMMENSETZUNGEN ZUR TOPISCHEN ANWENDUNG MIT EINEM PEROXID UND EINEM RETINOID[2009/43]
English:COMPOSITIONS FOR TOPICAL APPLICATION COMPRISING A PEROXIDE AND RETINOID[2009/43]
French:COMPOSITIONS POUR APPLICATION TOPIQUE COMPRENANT UN PEROXYDE ET UN RÉTINOÏDE[2021/29]
Former [2009/43]COMPOSITIONS D'APPLICATION TOPIQUE COMPRENANT UN PEROXYDE ET UN RÉTINOÏDE
Entry into regional phase26.08.2009National basic fee paid 
26.08.2009Designation fee(s) paid 
26.08.2009Examination fee paid 
Examination procedure31.07.2009Amendment by applicant (claims and/or description)
26.08.2009Examination requested  [2009/43]
14.11.2012Despatch of a communication from the examining division (Time limit: M02)
22.01.2013Reply to a communication from the examining division
27.01.2015Despatch of a communication from the examining division (Time limit: M04)
28.05.2015Reply to a communication from the examining division
11.11.2016Despatch of a communication from the examining division (Time limit: M06)
22.05.2017Reply to a communication from the examining division
25.09.2018Despatch of a communication from the examining division (Time limit: M06)
03.04.2019Reply to a communication from the examining division
30.09.2019Despatch of a communication from the examining division (Time limit: M06)
26.03.2020Reply to a communication from the examining division
14.07.2021Communication of intention to grant the patent
14.10.2021Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
23.11.2021Communication of intention to grant the patent
07.03.2022Fee for grant paid
07.03.2022Fee for publishing/printing paid
07.03.2022Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  14.11.2012
Opposition(s)23.01.2023No opposition filed within time limit [2023/13]
Fees paidRenewal fee
25.02.2010Renewal fee patent year 03
28.02.2011Renewal fee patent year 04
29.02.2012Renewal fee patent year 05
27.02.2013Renewal fee patent year 06
25.02.2014Renewal fee patent year 07
26.02.2015Renewal fee patent year 08
26.02.2016Renewal fee patent year 09
24.01.2017Renewal fee patent year 10
27.02.2018Renewal fee patent year 11
27.02.2019Renewal fee patent year 12
26.02.2020Renewal fee patent year 13
25.02.2021Renewal fee patent year 14
24.02.2022Renewal fee patent year 15
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT20.04.2022
BG20.04.2022
CZ20.04.2022
DK20.04.2022
EE20.04.2022
FI20.04.2022
HR20.04.2022
LT20.04.2022
LV20.04.2022
MC20.04.2022
NL20.04.2022
PL20.04.2022
RO20.04.2022
SE20.04.2022
SI20.04.2022
SK20.04.2022
NO20.07.2022
GR21.07.2022
IS20.08.2022
PT22.08.2022
[2024/51]
Former [2023/44]AT20.04.2022
CZ20.04.2022
DK20.04.2022
EE20.04.2022
FI20.04.2022
HR20.04.2022
LT20.04.2022
LV20.04.2022
MC20.04.2022
NL20.04.2022
PL20.04.2022
RO20.04.2022
SE20.04.2022
SI20.04.2022
SK20.04.2022
BG20.07.2022
NO20.07.2022
GR21.07.2022
IS20.08.2022
PT22.08.2022
Former [2023/25]AT20.04.2022
CZ20.04.2022
DK20.04.2022
EE20.04.2022
FI20.04.2022
HR20.04.2022
LT20.04.2022
LV20.04.2022
NL20.04.2022
PL20.04.2022
RO20.04.2022
SE20.04.2022
SI20.04.2022
SK20.04.2022
BG20.07.2022
NO20.07.2022
GR21.07.2022
IS20.08.2022
PT22.08.2022
Former [2023/09]AT20.04.2022
CZ20.04.2022
DK20.04.2022
EE20.04.2022
FI20.04.2022
HR20.04.2022
LT20.04.2022
LV20.04.2022
NL20.04.2022
PL20.04.2022
RO20.04.2022
SE20.04.2022
SK20.04.2022
BG20.07.2022
NO20.07.2022
GR21.07.2022
IS20.08.2022
PT22.08.2022
Former [2023/07]AT20.04.2022
DK20.04.2022
FI20.04.2022
HR20.04.2022
LT20.04.2022
LV20.04.2022
NL20.04.2022
PL20.04.2022
SE20.04.2022
BG20.07.2022
NO20.07.2022
GR21.07.2022
IS20.08.2022
PT22.08.2022
Former [2022/51]AT20.04.2022
FI20.04.2022
HR20.04.2022
LT20.04.2022
LV20.04.2022
NL20.04.2022
PL20.04.2022
SE20.04.2022
BG20.07.2022
NO20.07.2022
GR21.07.2022
IS20.08.2022
PT22.08.2022
Former [2022/50]AT20.04.2022
FI20.04.2022
HR20.04.2022
LT20.04.2022
LV20.04.2022
NL20.04.2022
PL20.04.2022
SE20.04.2022
BG20.07.2022
NO20.07.2022
GR21.07.2022
PT22.08.2022
Former [2022/49]AT20.04.2022
FI20.04.2022
HR20.04.2022
LT20.04.2022
LV20.04.2022
NL20.04.2022
SE20.04.2022
BG20.07.2022
NO20.07.2022
GR21.07.2022
PT22.08.2022
Former [2022/47]AT20.04.2022
FI20.04.2022
LT20.04.2022
NL20.04.2022
SE20.04.2022
NO20.07.2022
PT22.08.2022
Former [2022/44]NL20.04.2022
Cited inInternational search[X]US2002064541  (LAPIDOT NOA [IL], et al) [X] 1-26 * page 2, paragraph 18 * * page 3, paragraphs 26,44,47,48 * * page 7, paragraphs 114,130 * * page 8, paragraphs 131,135,140,142-144 * * page 9, paragraph 148 * * page 10, paragraphs 169,176,179 * * page 11, paragraphs 201-205 * * page 12, paragraphs 206-219 * * page 13, paragraphs 231,238 * * page 14, paragraphs 241-251 *;
 [A]WO2004064769  (HERRERA HECTOR [US]) [A] 1-26* the whole document *;
 [X]  - Martindale: the extra Pharmacopeia, USA, PHARMACEUTICAL PRESS, (1999), XP002477043 [X] 13 * page 1093 - page 1095 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.